These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 843155)

  • 1. Effect of splenectomy on teardrop-shaped erythrocytes in agnogenic myeloid metaplasia.
    DiBella NJ; Silverstein MN; Hoagland HC
    Arch Intern Med; 1977 Mar; 137(3):380-1. PubMed ID: 843155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splenectomy for agnogenic myeloid metaplasia.
    Coon WW; Liepman MK
    Surg Gynecol Obstet; 1982 Apr; 154(4):561-3. PubMed ID: 7064091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases.
    Brenner B; Nagler A; Tatarsky I; Hashmonai M
    Arch Intern Med; 1988 Nov; 148(11):2501-5. PubMed ID: 3190384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
    Mesa RA; Elliott MA; Tefferi A
    Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasia.
    Arora B; Ho CL; Hoyer JD; Mesa RA; Tefferi A
    Haematologica; 2004 Dec; 89(12):1454-8. PubMed ID: 15590395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythroleukemia following erythropoietin therapy, extramedullary hematopoiesis, and splenectomy in a patient with myelofibrosis and myeloid metaplasia.
    Coleman TA; Hamill RL; Ford SM
    Am J Hematol; 2001 Jul; 67(3):214-5. PubMed ID: 11391725
    [No Abstract]   [Full Text] [Related]  

  • 7. The syndrome of idiopathic myelofibrosis. A clinicopathologic review with emphasis on the prognostic variables predicting survival.
    Varki A; Lottenberg R; Griffith R; Reinhard E
    Medicine (Baltimore); 1983 Nov; 62(6):353-71. PubMed ID: 6633248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune haemolytic anaemia as the presenting manifestation of agnogenic myeloid metaplasia.
    Mohite U; Pathare A; al Kindi S; Hiwase D; Vadakkepat N; Knox-Macaulay H
    Haematologia (Budap); 2002; 32(4):495-9. PubMed ID: 12803124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agnogenic myeloid metaplasia; its current managment.
    Silverstein MN
    Minn Med; 1970 Mar; 53(3):257-9. PubMed ID: 5415744
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypersplenism. What it is and what not].
    Fischer J
    Internist (Berl); 1971 Apr; 12(4):176-86. PubMed ID: 4928640
    [No Abstract]   [Full Text] [Related]  

  • 11. Splenectomy in patients with agnogenic myeloid metaplasia: an analysis of 321 published cases.
    Benbassat J; Penchas S; Ligumski M
    Br J Haematol; 1979 Jun; 42(2):207-14. PubMed ID: 465366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenectomy for myelofibrosis.
    Järvinen H; Kivilaakso E; Ikkala E; Vuopio P; Hästbacka J
    Ann Clin Res; 1982 Apr; 14(2):66-71. PubMed ID: 7149614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks and benefits of splenectomy in myelofibrosis: an analysis of 39 cases.
    Lafaye F; Rain JD; Clot P; Najean Y
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):359-62. PubMed ID: 7892130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The choice between splenectomy and medical treatment in patients with advanced agnogenic myeloid metaplasia.
    Benbassat J; Gilon D; Penchas S
    Am J Hematol; 1990 Feb; 33(2):128-35. PubMed ID: 1689100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Splenic extramedullary hematopoiesis in myelofibrosis. Pathogenetic considerations apropos of a personally studied case].
    Piaserico PL; Piaserico GP
    Minerva Med; 1983 Oct; 74(39):2313-8. PubMed ID: 6657100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtotal splenectomy for treatment of patients with myelofibrosis and myeloid metaplasia.
    Petroianu A
    Int Surg; 1996; 81(2):177-9. PubMed ID: 8912088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Splenectomy in 5 patients with idiopathic myelofibrosis].
    Nozato A; Mizorogi F; Fukumi S; Watanabe H; Kobayashi M
    Rinsho Ketsueki; 2001 Aug; 42(8):627-32. PubMed ID: 11579502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with splenectomy in auto-immune thrombocytopenia and agnogenic myeloid metaplasia.
    Heaton A; Jacobs P; Dent DM; Louw JH
    S Afr Med J; 1976 Sep; 50(39):1506-12. PubMed ID: 988641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic.
    Mesa RA; Nagorney DS; Schwager S; Allred J; Tefferi A
    Cancer; 2006 Jul; 107(2):361-70. PubMed ID: 16770787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenectomy for the massively enlarged spleen.
    Danforth DN; Fraker DL
    Am Surg; 1991 Feb; 57(2):108-13. PubMed ID: 1992865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.